severe

Passage of the Amendment to the Advanced Regenerative Biotech Act a Positive Catalyst for Korean and Japanese Cell Therapy Companies

Source Node:
Time Stamp: February 7, 2024 10:49 AM - Modified On: February 7, 2024 - Published By:
Source Cluster:
Republished By Plato

Legislation Puts Renewed Focus on Next-Generation NK Cell Therapies New York, Feb 7, 2024 - (Plato Data) - On Thursday February 2, 2024, the bio industry welcomed the parliament’s passage of a bill that adds regenerative medicine organizations to the list of those considered for human cell management business licenses. The National Assembly passed the “Amendment to the Act on Safety and Support for Advanced Regenerative Medicine and Advanced Biopharmaceuticals” in a plenary session paving the way for certain next generation NK Cell Therapy companies to recognized as a licensed

NEW APPEAL TO PROVIDE SUPPORT TO THOUSANDS OF ISRAELI CITIZENS FOLLOWING HAMAS ASSAULT

Source Node:
Time Stamp: October 19, 2023 12:35 PM - Modified On: October 19, 2023 - Published By:
Source Cluster:
Republished By Plato

  Tel Aviv, New York & London; October 19, 2023: In the wake of the recent catastrophic and unprecedented attack that was launched at Israel by Hamas on and beyond October 7, Ahavat Yisroel Humanity Inc. has launched an urgent fundraising appeal in order to provide much-needed support and supplies to the thousands of Israeli citizens affected. The Israel Now, Israel Forever appeal is seeking donations to provide the many affected citizens with food, shelter, and urgent suppliers. The donations will be shared among four established and experienced relief organisations

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

Source Node:
Time Stamp: October 13, 2023 5:16 AM - Modified On: October 13, 2023 - Published By:
Source Cluster:
Republished By Plato

In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis in

Verofax to raise US$750,000 on Beban Crowdfunding Platform

Source Node:
Time Stamp: March 5, 2023 11:34 AM - Modified On: March 5, 2023 - Published By:
Source Cluster:
Republished By Plato

- Offering GCC retail investors interactive access to private equity investment opportunities BAHRAIN, Mar 5, 2023 - (ACN Newswire) - Verofax, the leader in brand marketing and AI-powered solutions for enterprise, was featured on Beban 2 (Episode 9, Mar 1, 2023), the hit entrepreneur & investment-themed reality TV program airing on Bahrain TV, Alrai TV and Dubai TV, as well as Shahid, the region's largest video-on-demand platform.   Wassim Merheby, CEO & Co-Founder, and Jamil Zablah, CMO & Co-Founder, Veromax, a product winning SaaS provider helping brands achieve growth by turning offline products interactive

xBacked Launches xUSD, a 110% Over-Collateralised Stablecoin for Algorand Positioned to Transform the DeFi Realm

Source Node:
Time Stamp: January 17, 2023 4:29 AM - Modified On: January 17, 2023 - Published By:
Source Cluster:
Republished By Plato

MEDIA RELEASE xBacked is a permissionless over-collateralized stablecoin protocol built on Algorand that allows anyone to use cryptocurrency without the volatility xBacked's decentralised stablecoin xUSD is available now to be minted on the platform, and aims to maintain a stable value of $1 USD backed by assets in the basket Stability pool, on-chain governance and TGE (token generation event) will be available in the coming months 17 JANUARY 2023: Launching today, xBacked is set to raise the bar with its over-collateralized stablecoin, xUSD. Built on Algorand and backed by multiple